지원사업
학술연구/단체지원/교육 등 연구자 활동을 지속하도록 DBpia가 지원하고 있어요.
커뮤니티
연구자들이 자신의 연구와 전문성을 널리 알리고, 새로운 협력의 기회를 만들 수 있는 네트워킹 공간이에요.
논문 기본 정보
- 자료유형
- 학술저널
- 저자정보
- 발행연도
- 2018.1
- 수록면
- 1,458 - 1,461 (4page)
이용수
초록· 키워드
오류제보하기
Myxofibrosarcoma is a rare tumor, refractory to cytotoxic chemotherapy and radiotherapy. Pembrolizumab is an innovative immunotherapy drug consisting of programmed death receptor ligand 1 antibody proven to be useful for numerous types of cancer cells. A patient had been diagnosed with metastatic myxofibrosarcoma, refractory to radiotherapy and conventional cytotoxic chemotherapy. The patient achieved a partial response during palliative chemotherapy with pembrolizumab for 14 cycles. To the best of our knowledge, this is the first case report demonstrating the efficacy of pembrolizumab for refractory myxofibrosarcoma.
목차
등록된 정보가 없습니다.
참고문헌 (15)
참고문헌 신청
Lazaros GA / 2008 / Primary myxofibrosarcoma of the left atrium: case report and review of the literature / Angiology 59:632~635
McMillan RR / 2013 / Recurrence patterns after resection of soft tissue sarcomas of the chest wall / Ann Thorac Surg 96:1223~1228
Kikuta K / 2013 / An analysis of factors related to recurrence of myxofibrosarcoma / Jpn J Clin Oncol 43:1093~1104
Goldberg SB / 2016 / Pembrolizumab for patients with melanoma or non-small-cell lung cancer and untreated brain metastases: early analysis of a non-randomised, open-label, phase 2 trial / Lancet Oncol 17:976~983
Zschabitz S / 2017 / Response to anti-programmed cell death protein-1 antibodies in men treated for platinum refractory germ cell cancer relapsed after high-dose chemotherapy and stem cell transplantation / Eur J Cancer 76:1~7
McMillan RR / 2013 / Recurrence patterns after resection of soft tissue sarcomas of the chest wall / Ann Thorac Surg 96:1223~1228
Kikuta K / 2013 / An analysis of factors related to recurrence of myxofibrosarcoma / Jpn J Clin Oncol 43:1093~1104
Goldberg SB / 2016 / Pembrolizumab for patients with melanoma or non-small-cell lung cancer and untreated brain metastases: early analysis of a non-randomised, open-label, phase 2 trial / Lancet Oncol 17:976~983
Zschabitz S / 2017 / Response to anti-programmed cell death protein-1 antibodies in men treated for platinum refractory germ cell cancer relapsed after high-dose chemotherapy and stem cell transplantation / Eur J Cancer 76:1~7
함께 읽어보면 좋을 논문
논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!
-
협부에 발생한 점액섬유육종 1예
대한이비인후-두경부외과학회지
2018 .01
-
Outcomes in Refractory Diffuse Large B-Cell Lymphoma: Results from Two Prospective Korean Cohorts
Cancer Research and Treatment
2023 .01
-
점액섬유육종과 점액성 지방육종의 비교분석
대한정형외과학회지
2022 .12
-
Chemotherapy : Is it needed?
대한외과학회 학술대회 초록집
2015 .11
-
Comparison of Efficacy of Pembrolizumab between Epstein-Barr VirusPositive and Negative Relapsed or Refractory Non-Hodgkin Lymphomas
Cancer Research and Treatment
2019 .01
-
Conversion surgery after palliative chemotherapy for metastatic gallbladder cancer
대한외과학회 학술대회 초록집
2019 .10
-
Patient-derived cancer organoid hub platform for refractory or rare cancer
한국실험동물학회 학술발표대회 논문집
2022 .07
-
Complete Remission after Pseudoprogression in Refractory Classical Hodgkin Lymphoma Treated with Pembrolizumab
대한내과학회지
2017 .01
-
췌장 및 담도암 환자의 항암 시작, 반응 평가 및 항암 중단 시점
대한췌담도학회지
2020 .01
-
Clinical Characteristics Associated with Long-term Survival in Metastatic Gastric Cancer after Systemic Chemotherapy
Asian Pacific journal of cancer prevention : APJCP
2015 .01
-
Clinical experience of immune checkpoint inhibitor for a metastatic jejunal cancer patient with a high tumor mutational burden and low expression of programmed death-ligand 1
KOREAN JOURNAL OF CLINICAL ONCOLOGY
2020 .06
-
Pembrolizumab for Patients with Relapsed or Refractory Extranodal NK/T-Cell Lymphoma in Korea
Cancer Research and Treatment
2024 .04
-
Analysis on Breast Cancer Refractory to Neoadjuvant Docetaxel Chemotherapy Following Adriamycin and Cyclophosphamide
대한외과학회 학술대회 초록집
2020 .11
-
Palliative Radiotherapy in the Presence of Well-Controlled Metastatic Disease after Initial Chemotherapy May Prolong Survival in Patients with Metastatic Esophageal and Gastric Cancer
Cancer Research and Treatment
2015 .01
-
The efficacy of chemotherapy in the patients with stage II colon cancer associated with number of high-risk factors
KOREAN JOURNAL OF CLINICAL ONCOLOGY
2018 .12
-
고령 암환자에서의 nivolumab과 pembrolizumab의 유효성과 안전성 평가
한국임상약학회지
2020 .01
-
Changes of Cognitive Function and Fatigue following Chemotherapy in Patients with Gastrointestinal Cancer: A Prospective Controlled Study
Asian Oncology Nursing
2019 .09
-
Efficacy and Safety of Pembrolizumab in Patients with Refractory Advanced Biliary Tract Cancer: Tumor Proportion Score as a Potential Biomarker for Response
Cancer Research and Treatment
2020 .01
-
The Prognostic Significance of Compliance with Postoperative Adjuvant Chemotherapy in Patients with Stage III Gastric Cancer: an Observational Study
Journal of Gastric Cancer
2018 .03
-
How to Support Nutrition for the Patients with Chemotherapy?
대한외과학회 학술대회 초록집
2020 .11
이 논문의 저자 정보
최근 본 자료
댓글(0)
0